Podcasts about industry dive

Sean Griffey and Ryan Willumson are the co-founders of Industry Dive, a digital media company delivering business news and original analysis through targeted newsletters. Covering sectors like healthcare, energy, transportation, retail, and more, Industry Dive serves over 14 million North American users and partners with major clients including Amazon, Salesforce, Uber, IBM, and American Express. The company is known for producing some of the most respected journalism in the business world. In this episode, Sean and Ryan discuss how they met while working at FierceMarkets, a B2B e-media startup, and what inspired them to launch Industry Dive. They share how they bootstrapped the company, built a loyal audience, and grew the business to $100 million in revenue before its acquisition by Informa in September 2022.

Meghan Weinman joined Carrix and SSA Marine in 2024 as Vice President of Sustainability. She is an industry leader across the sustainability, transportation, and environment sectors and has worked throughout North America and internationally, including Latin America, Asia, the Middle East, and Africa.  Prior to joining Carrix and SSA Marine, Ms. Weinman was a Managing Director at Edison Energy, leading the Transportation Electrification and Clean Energy Practice. She has also served in roles in management, engineering, and consulting across sustainability and built infrastructure. Ms. Weinman has served as a mentor for the Clean Tech Alliance, an industry advisor at Kellogg School of Management, and is also a frequent speaker on topics relating to sustainability, transportation, clean energy transition, climate, and women in leadership. Meghan Joins Sustainable Nation to Discuss: The scope of sustainability at SSA Marine and 2030 targets Decarbonization strategies including renewable energy sourcing Renewable diesel and hydrogen fuel options Advice and recommendations for sustainability professionals Meghan's Final Five Questions Responses: What is one piece of advice you would give to other sustainability professionals that might help them in their careers? Taking on different roles that strengthen understanding of the overall business is always something that would benefit sustainability. I started out in engineering, I went to business school, I'm now in my role today. That has been hugely helpful to understand different parts and wearing different hats and really being able to think cross functionally. With that, networking with other professionals not only in your industry, but adjacent industries. I always learn things when I talk to others in their roles. I had lunch with one of my colleagues who's at Alaska Airlines and we got to swap stories about how they're handling waste management. That was really helpful. Lastly, being a collaborative partner and really looking at how you can solve problems for stakeholders internally always is a way that can benefit not only sustainability, but the business overall.  What are you most excited about right now in the world of sustainability?  I'll go back to the answer that I gave around doing things that are really good for the business, but that can be sustainability initiatives. I get really excited about doing things that can be mutual wins across an organization. I've been working in electric vehicles now for almost 10 years through a couple of different roles, and there's been so much progress that's been made in terms of technological advancement. The commitment from automakers and equipment makers and increasingly the technology is becoming more and more of a mainstay, and that makes it easier and easier to incorporate into operations. It also brings about cost parity. Those are the things that I'm really getting excited about because it really is at a tipping point.  What is one book you'd recommend sustainability leaders read?  I'll give one book in two different categories. One that jump started my interest in sustainability over 20 years ago, and I'm sure this is probably known to most readers, was Natural Capitalism. That really helped me think about sustainability in a different way and really put into perspective the work that we're doing. But more recently I'm enjoying books that are at the intersection of business and can really help in a sustainability role, and so they're actually negotiation books, and you might wonder why negotiation. It's about coming up with solutions that may benefit many stakeholders across an organization and finding solutions that benefit potentially both sides. If you're thinking about how to convince your CFO or your commercial team, really think about it from a perspective of: how do I get what I want in sustainability, and also the finance team gets what they want. I'm going to give two books here, but one of them is Negotiate Without Fear by Victoria Medvec, and the other one is Getting to Yes, which is a classic by Roger Fisher and William Ury. Those are two that I would recommend any sustainability professional think about in terms of their own organization.  What are some of your favorite resources or tools that really help you in your work?  I really do like getting newsletters. I love reading and finding out what's happening across the industry. A couple that I like is ESG Dive from Industry Dive. That one I find to be really great information about what's happening across different companies, a blend of news and initiatives. I also really like Fortune's newsletters. Fortune has a number of newsletters, but one that has a lot of sustainability topics in there is the Trust Factor. They talk a lot about how sustainability and ESG is really paramount to businesses. But they also have other great newsletters too, like CEO Daily and CFO Daily, and they dabble into sustainability in those newsletters, too.  Where can our listeners go to learn more about you and the work being done at SSA Marine?  You can connect with me on my LinkedIn, Megan Weinman. You can also go to SSA Marine's LinkedIn page or visit our website, ssamarine.com to learn more about our work. Our sustainability report is on there. You can read more stories about things that we've been doing across the company, and our 2024 report will be in there too later on in 2025. 

Phoebe Bain is currently the Business & Finance Section Editor at ⁠1440⁠. In October 2024, she launched 1440's second-ever newsletter product, 1440 Business & Finance: a newsletter that provides more than 200,000 readers with the foundational knowledge they need to understand today's business news. Previously, she served as a senior reporter at Ad Age covering DTC brands, influencer marketing, and more. She was an early employee at Morning Brew, where she founded Marketing Brew, a newsletter and vertical covering the most important news in the marketing industry. Before rolling out Marketing Brew, Phoebe wrote for Social Media Today under Industry Dive, and worked on the social media editing desk for Business Insider.

In this "Industry Dive" episode, Chris Gehringer, a Senior Mastering Engineer & Partner at Sterling Sound joins me for an in-depth discussion on the state of mastering & the loudness wars in modern music. Chris has mastered countless albums over the decades, such as: Wu-Tang Clan's “Enter The Wu-Tang (36 Chambers)” & Naughty By Nature's 1991 self titled album, along with modern chart toppers such as Rhianna, Lady Gaga & Dua Lipa. Chris' work has also received 20 Grammy nominations (and counting). In the episode, we talk about: the evolution of music mastering; where the loudness war stands in 2025; how brickwalling hinders the mastering process; if there will ever be an industry shift towards "louder doesn't mean better;" Eric Bass of Shinedown's experiences with Sterling Sound's Ted Jensen & how Eric prefers a more dynamic master of their music; how Chris was involved with the interludes featured on Wu-Tang Clan's "Enter The Wu-Tang (36 Chambers);" the loudness / brickwalling controversy surrounding Metallica's "Death Magnetic;" how Dolby Atmos & AI might factor into the future of mastering & so much more! Be sure to visit MyWeeklyMixtape.com to hear all of the songs we discussed in this episode!  Theme music is "Unveiled" by The 4th. You can find the album on Spotify, Apple Music, Amazon Music, Pandora, YouTube, Bandcamp & more! FOR MORE ON MY WEEKLY MIXTAPE Website: http://www.myweeklymixtape.com Patreon: https://www.patreon.com/myweeklymixtape Facebook: http://www.facebook.com/myweeklymixtape X: https://x.com/myweeklymixtape Instagram: https://www.instagram.com/myweeklymixtape Threads: https://www.threads.net/@myweeklymixtape  Blusky: https://bsky.app/profile/myweeklymixtape.bsky.social  TikTok: https://www.tiktok.com/@myweeklymixtape Learn more about your ad choices. Visit megaphone.fm/adchoices

In this Industry Dive, as well as in celebration of Record Store Day 2025, here's a Tunestiles Throwback interview with RSD co-founder Carrie Colliton, where we dig deep into the history of the event, the RSD Ambassadors they've had over the years (including Metallica, Jack White, Josh Homme, Foo Fighters and more!), the process on securing exclusive RSD releases from artists, the live events that surround the day, dealing with social media noise, record flippers and most importantly, the celebration of indie record stores! Theme music is "Unveiled" by The 4th. You can find the album on Spotify, Apple Music, Amazon Music, Pandora, YouTube, Bandcamp & more! FOR MORE ON MY WEEKLY MIXTAPE Website: http://www.myweeklymixtape.com Patreon: https://www.patreon.com/myweeklymixtape Facebook: http://www.facebook.com/myweeklymixtape X: https://x.com/myweeklymixtape Instagram: https://www.instagram.com/myweeklymixtape Threads: https://www.threads.net/@myweeklymixtape  Blusky: https://bsky.app/profile/myweeklymixtape.bsky.social  TikTok: https://www.tiktok.com/@myweeklymixtape Learn more about your ad choices. Visit megaphone.fm/adchoices

Sean Griffey, until recently the CEO of Industry Dive, joined me on The Rebooting Show to discuss the big things Industry Dive, and by extension a lot of B2B, got right. Sean was rarely mentioned in the collection of digital media CEOs of the recent decade. Yet Industry Dive achieved one of the standout exits of the category. He led the B2B publishing company to a $525 million exit to Informa. At the end of 2024, Sean left his role at Informa TechTarget to enjoy “semi-retirement.” I've found over the recent years that the worlds of consumer and business publishing are coming together. It used to be they spoke differently and had different priorities. Now, you have publishers like Punchbowl and Puck executing B2B strategies. Semafor relies on events as the bulwark of its revenue model. Publishers are more likely to talk up their newsletters than ComScore numbers.Some of the lesions we discussed:Focus on a specific audience. Industry Dive would turn off ads if it had a story picked up by Reddit that led to a flood of viral traffic. That's because the people arriving weren't the “right people.” B2B isn't about reaching everyone. Know who you're writing for. A trick of B2B that narrows the focus: Write for a specific job title. Media properties nowadays can be messy, but they need to have a person in mind (and know enough similar people exist).Get receipts. Industry Dive focused its business model on marketing services and lead generation. In B2B, budgets are far greater for demand generation than branding or thought leadership. Do more with less. Industry Dive operated dozens of publications in verticals like wast management, retail, marketing and Tk. But it operated a single platform. That allowed it to quickly move to create new brands, even if it sacrificed unique branding elements.Go direct. Media companies have three core areas: creation, distribution and monetization. Sean criticizes consumer publishers for relinquishing control over distribution by chasing search and social traffic and monetization by relying on programmatic advertising middlemen. B2B media markets have developed differently, allowing companies to avoid those kinds of dependencies.

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world. Democrats have introduced a bill to make increased Affordable Care Act (ACA) subsidies permanent, arguing that if the enhanced tax credits expire, healthcare costs for millions of Americans will suddenly increase. Meanwhile, the Senate has voted unanimously to hold Steward Health Care CEO Ralph de la Torre in criminal contempt, marking the first time in over 50 years that such a charge has been sent to the U.S. Department of Justice. Additionally, the Centers for Medicare & Medicaid Services (CMS) is holding Accountable Care Organizations harmless for "highly suspect" Medicare billing practices. A home care agency has settled allegations that it accommodated "race-based requests" for aides, with the Equal Employment Opportunity Commission stating that the agency terminated assignments of black and Hispanic aides to adhere to patients' and family members' racial preferences. The top tech trends transforming healthcare today include leveraging new technologies to navigate workforce shortages, economic pressures, and consumer demands.Arch Venture Partners has raised $3 billion for a new fund to support AI biotech startups. Pfizer has pulled its sickle cell therapy, Oxbryta, from the market due to safety concerns. A study suggests that Novo Nordisk's Ozempic may lower the risk of opioid overdose in diabetics. Research has cast doubt on the benefit of anti-CD20 therapies in multiple sclerosis. The setback with Oxbryta has caused frustration among investors regarding Pfizer's business development track record. Novo and Evotec have partnered for stem cell research, while cancer and diabetes drugs are expected to dominate Medicare negotiations in 2025.Pfizer is pulling its sickle cell drug from the market and shutting down trials due to safety concerns. BioAge successfully priced a $198 million IPO, focusing on obesity drug research. An Italian biotech received $52 million to advance pediatric gene therapies. Arch raised another $3 billion biotech fund to pursue innovative science. The industry is seeing advancements in GLP-1 drugs and exploring new treatments for obesity.Roivant, led by CEO Matt Gline, has found success in the biotech industry by taking a unique approach to acquiring and selling assets from big pharma companies. Despite Gline's lack of experience in biotech, Roivant has weathered the tough biotech climate and generated substantial cash flow. The company's strategy involves investing in products that do not fit into the traditional categories of big pharma, leading to successful acquisitions and partnerships.Placer.ai's latest report explores the potential benefits of offering healthcare services in grocery stores to increase foot traffic and customer loyalty. The report delves into how the addition of a healthcare clinic can impact grocery store visitation patterns, which types of consumers are most likely to visit grocery stores with healthcare offerings, and how loyalty rates differ between stores with wellness centers and those without.Abcam offers antibodies, proteins, kits, and reagents for life science research, with a focus on immunoassays that accelerate throughput. Their SimpleStep ELISA kits provide fast results in 90 minutes or less with high sensitivity, specificity, flexibility, and reproducibility. The 384-well format allows for efficient scaling up with consistent results across labs. For more information on their immunoassays and advertising opportunities, contact Abcam directly. This message is part of a complimentary newsletter subscription to Biopharma Dive, a product of Industry Dive, Inc.

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world. Amazon has partnered with Talkspace to expand its digital health benefits program, which also includes Omada Health. Community Health Systems (CHS) subsidiary is acquiring 10 urgent care centers, following in the footsteps of other for-profit health systems. Steward Health Care auctioned off Glenwood Regional Medical Center for $500,000, but there are concerns about the continued involvement of hospital landlord Medical Properties Trust in operations. The text also includes sponsored content on safeguarding healthcare against ransomware and cybercrime, as well as information on trends in telehealth and strategies for improving provider data accuracy for payers. Healthcare Dive provides news and insights for healthcare leaders and is a publication operated by Industry Dive.Roivant's subsidiary, Dermavant, is being acquired by Organon, giving Organon access to a psoriasis and eczema cream called Vtama. This acquisition will provide Roivant with additional cash to fund its research and development plans. Meanwhile, biotech M&A activity has plateaued, with private company acquisitions continuing while public company acquisitions have slowed down. One biotech, Ratio Therapeutics, backed by Bristol Myers Squibb, is optimistic about the boom in radiopharma and the pharmaceutical industry's shift towards targeted radiation drugs. In other news, Novartis' Kisqali has received expanded FDA approval which could double its market for breast cancer treatment. Additionally, Express Scripts is suing the FTC over a report critical of pharmacy benefit manager business practices. The industry is also exploring new ways to deliver genetic therapies and improve clinical trial execution through systems thinking. Overall, the biopharma industry is experiencing exciting times with various developments and advancements in drug development and healthcare technology.Zimmer has decided to pull its hip implant off the market due to fracture risk, with plans to phase out its use by December. Merit Medical has acquired Cook's lead management business for $210 million, adding devices used in heart rhythm device procedures to its portfolio. Synchron has connected brain-computer interface technology to Amazon Alexa, allowing patients to control various functions without using their hands or voice. Senseonics has received FDA clearance for a one-year continuous glucose monitoring system, and Boston Scientific has closed its acquisition of Silk Road Medical. The wearables market is expected to grow by 13% annually between 2024 and 2030, highlighting the importance of adhesives in wearable device development. AI is increasingly influencing the value chain of medical device companies, and manufacturers are exploring ways to utilize AI throughout the product lifecycle. These developments reflect the ongoing innovation and evolution within the medtech industry.Roivant has sold Dermavant to Organon in a deal worth up to $1.2 billion, allowing Roivant to focus on their autoimmune-focused Immunovant and upcoming trials. Summit Therapeutics' bispecific for non-small cell lung cancer has shown promise against Keytruda but still needs more data. Other news includes the FDA approving Keytruda for pleural mesothelioma, Bernie Sanders claiming generics companies can offer a cheaper alternative to Ozempic, Novartis expanding Kisqali's use in breast cancer, and HRSA threatening sanctions against J&J. In the world of enzyme development, SignalChem Biotech offers tailored services. Additionally, new gene therapies for sickle cell disease are reaching patients, and the race for an obesity pill is heating up among companies like Novo, Roche, and Terns.The FDA is facing challenges with conducting overseas drug manufacturing inspections, with 42% of registered plants overdue for inspections. Indian drugmaker Zydus Lifesciences received a warnin

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world. A new healthcare AI accelerator program has been launched by Johns Hopkins, CareFirst, and Techstars, offering funding and guidance to startups working on AI tools. Medicare could face increased spending of $34 billion to $145 billion annually if all newly eligible patients received coverage for weight loss drug semaglutide. Pfizer has launched a direct-to-consumer service for migraine, COVID-19, and flu treatments similar to one by Eli Lilly. Johnson & Johnson plans to reform the 340B drug discount program, causing concern among hospitals and the government. Healthcare Dive provides insights into healthcare venture trends and offers resources on improving patient outcomes with data and AI technology. The publication covers news on various healthcare topics such as health IT, payer-provider partnerships, and value-based care. Healthcare Dive is operated by Industry Dive, providing in-depth journalism for decision-makers in competitive industries.On August 27th, Lilly introduced cheaper vials of Zepbound, a weight loss medicine, to compete with telehealth companies. Pfizer also launched a direct-to-consumer service for their migraine, COVID-19, and flu treatments, following in the footsteps of Eli Lilly. In other news, a startup backed by RA Capital raised $100 million for developing drugs for immune diseases, while UCB sold its neurology and allergy business in China. Additionally, Versant's Jerel Davis discussed build-to-buy deals and pharma investment strategies. The industry is moving towards more patient-centric commercialization strategies, with companies like Pfizer and Lilly breaking into the DTC market. This shift aims to give consumers easier access to treatments and improve supply chain efficiency. Pharmaceutical companies are exploring new partnerships and strategies to accelerate drug development and improve patient outcomes.Eli Lilly has reduced the price of its drug Zepbound by offering single-dose vials at a 50% discount through its online pharmacy LillyDirect. This move aims to expand the supply of Zepbound and make it more accessible to patients. In other news, a study suggests that Medicare coverage of Novo Nordisk's semaglutide for cardiovascular disease could cost $145 billion annually, depending on the number of eligible patients. Additionally, Cigna plans to remove AbbVie's Humira from its formularies, Oculis closes a phase III eye drop trial due to an administrative error, and Regeneron gains EU approval for a bispecific antibody for lymphoma. Furthermore, there have been lay-offs in the biopharma industry, and Massachusetts' biopharma job growth has slowed in 2023. Interested individuals can register for upcoming webinars and explore job opportunities in the biopharma field.

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world.Medicare has revealed the results of drug price negotiations, showing $6 billion in savings for taxpayers from talks involving drugs like Eliquis and Xarelto. Lilly has opened an R&D hub in Boston, while Ovid and Lexicon are facing layoffs. A journal has retracted papers on MDMA-assisted therapy, and Evotec is cutting jobs and exiting gene therapy. Galderma has received FDA approval for a skin condition treatment, and trends in cell therapy research and market strategies of pharma giants are being explored. The impact of AI technology on clinical trials, patient-centric commercialization strategies, and upcoming events in the biopharma industry are also discussed.Texas is suing the Biden administration over a nursing home staffing mandate requiring at least 3.48 hours of care per resident each day. A report accuses HCA of driving away doctors and downgrading care at Mission Hospital after acquiring it. Medicare drug price cuts may have limited early impact but could have bigger future implications for drug research. Nurses may need their own AI documentation tools due to complex work and shifting tasks. Additionally, Medicaid has overtaken Medicare Advantage as a concern for health insurers in the second quarter. The text also includes information on updating healthcare sales approaches and using data to improve patient outcomes.Pfizer and BioNTech's COVID-flu shot candidate faced setbacks in Phase III trials, potentially giving Moderna an advantage with its superior vaccine. Medicare negotiated drug prices touted by the Biden-Harris administration are criticized as hollow victories. Other news includes Lycos slashing its workforce, Bavarian Nordic's potential windfall with an emergency vaccine, and AstraZeneca's Imfinzi scoring FDA approvals. Layoff announcements in the biopharma industry are also highlighted. The role of Quality Assurance and Regulatory Affairs (QARA) professionals in market access is explored.Walmart's ad unit has experienced significant growth, with ad sales from marketplace sellers increasing by nearly 50% in fiscal Q2. The digital economy is expected to expand, particularly in online retail and online travel. Marketers are increasingly turning to first-party data strategies and behavioral data to enhance their marketing efforts. Industry Dive provides insights and news for marketing leaders, covering topics such as brand strategy, social media, video marketing, and more. Companies can post press releases on Marketing Dive to share announcements with a wide audience.

Good morning from Pharma and Biotech Daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.Biotech veteran Art Krieg has postponed his retirement to start a new drug startup called Zola Therapeutics, focusing on cancer immunotherapies without outside investors. Stoke's shares surged on updated results for their drug for Dravet syndrome, a form of genetic epilepsy. Moderna received backing from Blackstone for flu vaccine research and development. Armon Sharei, founder of the now-liquidated SQZ Biotechnologies, is starting over in biotech with a focus on cell therapies. The newsletter Gene Therapy Weekly provides insights into the latest news and trends in the biopharma industry, covering topics such as clinical trials, FDA approvals, gene therapy, and more. Industry Dive's Biopharma Dive publication offers in-depth journalism and analysis for decision makers in the biotech and pharma sectors.CVS has entered the biosimilar drug market with a new venture, as more than three dozen biosimilars have been approved in the U.S. However, their impact has been limited by patent thickets and insurance contracting that favors brand-name drugs. Despite this, there are signs that biosimilars are gaining momentum. Other stories in the biosimilars market include biosimilar makers adopting different strategies to compete with top-selling drugs like Humira, and Sandoz spinning out of Novartis to become a standalone generic drugmaker. This trendline provides insights into the state of the biosimilars market and is independently produced by journalists. Sponsorship opportunities are available for those interested in reaching biopharma industry executives. Biopharma Dive is a product of Industry Dive, Inc. located in Washington, DC.Walgreens has experienced a $6 billion loss due to the depreciation of the value of VillageMD, resulting in the closure of 140 VillageMD locations. CMS has implemented new regulations to streamline Medicaid and CHIP enrollment processes. UCI Health has completed a $975 million purchase of four Tenet hospitals, while Ascension is divesting three hospitals in northern Michigan. Additionally, over 2,000 nurses are planning to strike in Santa Clara County. Healthcare organizations are facing challenges related to staffing shortages, and technology is being recommended as a solution. UnitedHealth is offering loans to providers affected by cyber attacks, and efforts are being made to keep 'site neutral' policies alive. University of Michigan Health workers have unionized. Healthcare Dive provides insights on various topics including health IT, policy and regulation, insurance, digital health, and value-based care.

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world.UnitedHealth is offering financial assistance to providers affected by a cyberattack on Change Healthcare, but providers say it is not enough to cover the financial strain. CVS and Walgreens will begin selling the abortion pill, mifepristone. Hospital compliance with price transparency requirements is declining due to lenient enforcement. The cyberattack on Change Healthcare is causing widespread effects on providers, impacting billing, eligibility checks, prior authorization requests, and prescription fulfillment.In other news, a report shows that 2 out of 3 healthcare firms find their digital transformation efforts ineffective, and a watchdog group highlights the importance of adopting a platform-based strategy in healthcare. This newsletter provides daily news and insights for healthcare leaders and is sponsored by Paylocity, offering HR and payroll software solutions. Healthcare Dive is a publication operated by Industry Dive, providing in-depth journalism and insight into the most impactful news and trends shaping healthcare.Pfizer's decision to focus on biologics over small molecules in its oncology strategy was influenced by the Inflation Reduction Act. This act's drug price negotiation provisions led Pfizer to build up its biologics portfolio and reduce small molecules. Meanwhile, new ALS treatments are facing regulatory uncertainty despite the approval of two novel therapies for the disease.The ALS treatment landscape is filled with over 100 candidates, and experts suggest that regulatory standards and expectations are still evolving. Bayer paid $310 million to BridgeBio for an ATTR-CM treatment in Europe as BridgeBio's Acoramidis nears an FDA approval decision. Additionally, Akero Therapeutics' Efruxifermin showed positive mid-stage fibrosis data, improving fibrosis without worsening metabolic dysfunction-associated steatohepatitis.The text also mentions other news in the biopharma industry, such as J&J's full FDA approval for Rybrevant and a pilot study showing that better eConsents create better human experiences. Finally, it promotes registration for Bio 2024, the world's largest biotech event, where leaders in business, science, and policy can come together for innovation and partnering opportunities.

Good morning from Pharma and Biotech Daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.UnitedHealth is facing an antitrust probe by the DOJ regarding potential anticompetitive effects. Despite challenges like high labor costs, UHS, a hospital operator, saw revenue growth in 2023. Veradigm is set to delist after missing a Nasdaq deadline. Nurse leaders report burnout and turnover in their roles. A ransomware attack at an urgent care provider may have exposed personal information of over 516,000 people. Healthcare Dive provides insights for healthcare leaders, including articles on AI implementation, social determinants of health, and healthcare data breaches, covering a wide range of topics such as hospitals, payers, health IT, government policies, finances, medical groups, and telehealth. Healthcare Dive is operated by Industry Dive, providing journalism and insights for decision-makers in competitive industries.Viatris pays $350 million to acquire two drugs from Idorsia for heart attacks and lupus in phase 3 testing. Ginkgo acquires gene editing tools through the buyout of Proof Diagnostics, founded by Feng Zhang. Incannex reports that psilocybin therapy reduced anxiety in a small study. Women's health company Obseva plans to wind down operations and lay off staff. Viking's obesity drug showed promising results in a phase 2 trial, potentially rivaling drugs from Eli Lilly and Novo Nordisk. The rise of obesity drug treatments is reshaping the pharma industry with significant advancements and changes, as companies make strategic moves to enhance their portfolios and address unmet medical needs.Gatorade has unveiled Gatorade Water, their first unflavored water product, with a digital-heavy marketing campaign focused on wellness. Estee Lauder's marketing mix modeling use was discussed at the eTail Palm Springs conference, showcasing their balance between brand and performance marketing. Dick's Sporting Goods has enlisted Kathryn Hahn and Will Arnett for an ad campaign highlighting e-commerce convenience. Food and beverage brands are putting a modern spin on retro packaging to appeal to consumers' emotions. Mod Op has acquired RTO+P for more creative firepower in a competitive market. Marketing Dive explores mobile messaging's influence on consumer behavior in 2024, as well as upcoming events and industry news.The recent awarding of Johnson & Johnson's Dr. Paul Janssen Award for Biomedical Research to MIT professor and Moderna co-founder Robert Langer is discussed in the text, recognizing his impactful innovations in drug delivery. Langer's work in nanoparticle drug delivery has led to advancements in biopharma, particularly in the technology behind mRNA vaccines. The text also highlights Langer's role as a scientific advisor to a new CRO aiming to improve clinical trials through technology. Additionally, it addresses the staffing challenges faced by CROs since the pandemic and explores strategies for retaining talent in the research industry, emphasizing the importance of adapting to new technologies and approaches to enhance efficiency in clinical trials and improve patient care.

With over 20 years of experience in eCommerce technologies, Peter Sheldon is a recognized industry leader and former VP and Principal Analyst at Forrester Research. He has helped numerous eCommerce executives and brands to challenge their thinking and lead change in their digital transformation and commerce technology programs.As the SVP Strategy and Growth at Maergo, Peter sets the strategic vision and drives the market expansion for a first-of-its-kind parcel delivery platform, purpose-built for branded direct-to-consumer delivery. He leverages his deep expertise and network in eCommerce platforms, mobile commerce, content management, payment systems, and supply chain technologies to create innovative solutions and partnerships that disrupt the incumbent carriers and empower the largest and fastest growing brands to increase sales and customer satisfaction. Peter is passionate about delivering exceptional customer experiences and enabling the future of eCommerce.Harshida Acharya, Partner and CSO at Fulfillment IQ, has played a significant role in the company's multi-million-dollar growth. She is recognized as a top eCom Influencer by Shopify. Her expert insights have been published in Forbes, Industry Dive, and Supply Chain and Demand Executive, to name a few. Harshida wears multiple hats. She's also the creator and producer of the eCom Logistics Podcast, a podcast ranked amongst the top 5% globally and is one of the most shared business podcasts of all times. She is also actively involved in venture capital firms, serving as an investor, member, and advisor to emerging startups. Harshida's a passionate advocate for diversity and inclusion, actively fostering a community of women in supply chain and mentoring the next generation of professionals. Her efforts have earned her recognition, including the Women in Supply Chain 2023 Award.  SHOW SUMMARYIn this episode of eCom Logistics Podcast, Dan Coll and Ninaad Acharya share their experiences and key takeaways from Manifest 2024, a premier e-commerce and logistics conference. During the conference, Ninaad is joined by Harshida and Peter to discuss the focus on the evolving landscape of returns, last-mile delivery challenges, and the transformative power of partnerships and emerging technologies in the e-commerce supply chain.HIGHLIGHTS[00:00:22] Partnering for Data Power: Explore the transformative potential of partnerships in the e-commerce space, emphasizing the sharing of data among vendors to drive efficiency and overcome challenges.[00:01:42] Manifest 2024 Highlights: A deep dive into the significance of Manifest 2024, discussing the unique mix of attendees, emerging companies, and the event's LinkedIn in real life (IRL) vibe.[00:05:19] E-commerce Market Opportunities: Insights into integration work as a growing opportunity in the market, with a focus on transportation, last-mile delivery, and the strategic placement of investment dollars.[00:08:43] Last Mile Evolution: Uncover the importance of last-mile delivery in the e-commerce landscape, exploring strategies to streamline and optimize this critical aspect of the supply chain.[00:11:29] AI and People in Harmony: Understand the role of AI in e-commerce while emphasizing the synergy between technology and human involvement, particularly in the context of automation and upskilling.[00:18:40] Data-Driven Returns Management: A closer look at leveraging data to tackle the challenges of returns, including bracketing and the potential for retailers to adjust return policies based on consumer behavior.[00:22:18] Resale and Circular Economy: Delve into the rising importance of the circular economy, resale markets, and how brands are actively participating in sustainable practices.[00:27:29] 2024 Tech Outlook: Explore the shifting dynamics in technology investments for 2024, with a focus on enhancing the consumer experience, accelerating shipping, and adapting to the changing economic landscape.QUOTES[00:05:52] "There's a big opportunity in the market for integration work, and a lot of conversation around all things integrations."[00:11:11] "As leaders focus on providing the right tools to your employees, it enriches the quality of their life and work."[00:18:40] "The data allows us to challenge the norms of, 'It's either free returns or it's not.'"[00:22:18] "The dynamics are changing so fast, between liquidation B2B, B2C, and things like resale."Find out more about Peter Sheldon in the link below:LinkedIn: https://www.linkedin.com/in/petersheldon/

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in the Pharma and Biotech world. In the commercialization news for the biopharma industry this week, there are several key updates. Novartis has delayed the FDA filing for its radiopharma drug, Pluvicto, due to mixed survival data from a study in earlier prostate cancer. This has led to a slower regulatory timeline. Merck has made a significant investment in the field of antibody-drug conjugates (ADCs) through a deal with an alliance. This move follows similar investments by Pfizer, AstraZeneca, and Gilead, highlighting the potential for ADCs to reshape cancer treatment. Pfizer has also received FDA approval for its new meningococcal vaccine, Penbraya, which adds to its infectious disease portfolio as it adjusts to declining sales of COVID-19 vaccines. Roche reported growing sales of its eye drug Vabysmo in the US market, while Regeneron tries to catch up after a delay in its high-dose Eylea. The CDC has asked doctors to ration the supply of Sanofi and AstraZeneca's new RSV drug, Beyfortus, due to high demand outstripping supply. Additionally, PTC Therapeutics has agreed to sell spinal muscular atrophy drug royalties for $1 billion in order to retire debt and have more cash for future operations. These updates highlight the ongoing developments and challenges in the biopharma industry as companies navigate regulatory timelines, make strategic investments, and address supply shortages.Moving on, Cardinal Health's Sonexus Access and Patient Support program is being promoted as a solution for improving patient hub strategies. The program aims to reach more patients and help them start therapy more quickly while also reducing labor costs through digital interactions. Cardinal Health facilitates smooth program transitions to ensure minimal disruptions in treatment journeys and improve patients' lives. A 3-step guide to patient hub transition is available online. This information is provided as part of a complimentary newsletter subscription from Biopharma Dive, a product of Industry Dive.Amgen is set to lay off 350 employees from its Horizon subsidiary, bringing its total number of job cuts this year to over 1,000. This move comes just weeks after Amgen closed a $28 billion deal to acquire Horizon. Meanwhile, there is a supply shortage of the infant respiratory syncytial virus (RSV) antibody drug Beyfortus. The CDC has asked doctors to ration the supply of the drug as demand has exceeded supply. Excision, a biotechnology company, has given a first look at its gene editing therapy for HIV. Although the results are from a small study with only three participants, they offer insight into how one of the few in vivo CRISPR therapies in human testing in the US is working. Patient groups have become increasingly influential in drug research and development (R&D), with their funding influencing drug development, according to the director of the IQVIA Institute for Human Data Science. J&J MedTech Head Ashley McEvoy is set to step down from her position after 27 years with the company to pursue other opportunities. Tim Schmid will now lead J&J's MedTech business.These updates provide valuable insights into the current happenings and trends in the Pharma and Biotech industry. Stay tuned for more important news in our next episode.

After nearly 300 episodes we have had some of the most spectacular guests on the podcast! Every once in a while we like to bring back one of our favorite episodes from the archives because we really enjoyed the conversation and think our new listeners will as well. This week we chat on the complexities and opportunities smart cities can deliver in the US and around the globe with guest Chris Teale, reporter at Smart Cities Dive. He's spent years meeting with government and community leaders on the growth of smart cities and shares thoughts on just how fluid defining what a smart city is today. Learn which cities around the world are leading in the smart city evolution and how a patchwork of state-by-state laws and regulatory frameworks help and/or hinder progress. As well as examples of US cities you may not have expected that can share best practices and lessons learned with cities large and small across the country to help get them on the path to better utilizing technology and digitization to improve essential services (such as trash pick-up)  and quality of life. He also shares insights of the ‘hackers as city consultant' trend and how a federal government playbook for cities could help more cities get smarter, faster. Chris Teale, Reporter, Smart Cities Dive Chris is a reporter at Smart Cities Dive. He came to Industry Dive in February 2018 after spells in general assignment reporting in Alexandria and Arlington, Virginia. Chris graduated from the University of East Anglia in 2013, and moved to the Washington, D.C. area shortly after.   For links and resources discussed in this episode, please visit our show notes at https://www.forcepoint.com/govpodcast/e244

Erik Torenberg sits down with Sean Griffey, CEO and Co-founder of Industry Dive, a business journalism company that reaches 14 million executives across 32 publications, and was acquired by Informa for $525 million. Riverside.fm is a presenting sponsor of Media Empires. Go to https://creators.riverside.fm/MediaEmpires + use code MEDIAEMPIRES for 20% off individual plans.We're hiring across the board at Turpentine and for Erik's personal team on other projects he's incubating. He's hiring a Chief of Staff, EA, Head of Special Projects, Investment Associate, and more. For a list of JDs, check out: eriktorenberg.com.RECOMMENDED PODCAST:Founding a business is just the tip of the iceberg; the real complexity comes with scaling it. On 1 to 1000, hosts Jack Altman and Erik Torenberg dig deep into the inevitable twists and turns operators encounter along the journey of turning an idea into a business. Hear all about the tactical challenges of scaling from the people that built up the world's leading companies like Stripe, Ramp, and Lattice. Our first episode with Eric Glyman of Ramp is out now: https://link.chtbl.com/1to1000RECOMMENDED PODCAST:Run the Numbers is a weekly podcast about financial metrics and business models, designed for ambitious people operating tech startups. It's a collection of things host CJ Gustafson (CFO at Partstech and writer of Mostly Metrics) has learned and thought about in the trenches as a tech CFO. Subscribe to listen on the platform of your choice: https://link.chtbl.com/runthenumbersMedia Empires is part of the Turpentine podcast network. To learn more: www.turpentine.coIn this conversation, Erik and Sean discuss the story of how Industry Dive came to be, how Sean evaluates acquisition deals and talent in the media space, and what Sean would do differently if he started building Industry Dive in 2023.TIMESTAMPS(00:00) Episode Preview(01:13) Sponsor: Riverside.fm(02:29) The story of Industry Dive(04:58) The evolution of business media(07:05) What did everyone miss in the consumer media space?(08:17) Business media models and their tradeoffs(12:27) Industry Dive's value prop(15:34) How Sean evaluates acquisition deals(18:40) Choosing a media platform(22:35) What Sean would do differently if he started Industry Dive today(28:22) Sean's dream acquisition(29:42) Building a viable initial audience(34:12) Substack(36:56) Data worth collecting and evaluating in media(40:42) Advice for evaluating talent in mediaLINKS:IndustryDive: https://www.industrydive.com/TWITTER:@seangriffey (Sean)@industrydive (Industry Dive)@eriktorenberg (Erik)@MediaEmpiresPod (Media Empires) This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit mediaempires.substack.com

⁠Thanks to Kerv ⁠for sponsoring this episode. To see Kerv's technology at work, ⁠check out Peacock's MustShop TV⁠. If you'll be on the Cote d'Azur next month. The New Attention Economy, presented by Kerv, will have speakers from the Financial Times, Uber, Paramount, Havas and more. Let's talk ‘Active Attention' Economy at Cannes Join us for three days of exclusive thoughtful conversations and cocktails with the industry's best to discuss the Attention Economy and the future of publishing, streaming, AI & creativity. Register here. Last week, I traveled to Washington DC to record a podcast with Sean Griffey, CEO of Industry Dive. I've known Sean and Industry Dive a while, mostly because two of its 33 publications – Marketing Dive and Retail Dive – were in areas in which my previous companies had publications. Sean was also the rare media CEO who would come onto my podcast and not rattle off a bunch of talking points. The big numbers he talked about weren't Facebook video views of ComScore uniques ginned up through traffic assignment schemes. He spoke about revenue and, imagine, EBITDA.  Industry Dive went on to be bought not once but twice. First in a transaction to growth equity firm Falfurrias Capital in 2019 and then last year in a deal to events giant Informa last year that Axios reported put an enterprise value on Industry Dive of $525 million. That would make Industry Dive's value at over two Vices and five BuzzFeeds. What Industry Dive got right is something I covered after the Informa deal. I was long impressed by Sean and Industry Dive's management ability to stay focused and disciplined in their business model. It helped that Industry Dive didn't raise venture capital. Constraints can be good. It meant focusing on what was working, notably newsletters and being good at putting first-party data to use for B2B marketers. In B2B, the pull to do events – have you signed up for The Rebooting's Cannes events yet? – is strong. That's because B2B doesn't have advertisers per se, but marketers. And B2B marketers serve to get their sales teams prospects. That leads many B2B publications to go heavily to events.  Industry Dive skipped events because it was very good at building publications in high value industries with tons of regulation and tech-driven change and acting as a critical marketing partner. That isn't revolutionary. But it's hard to execute. Another aspect that impressed me about what Industry Dive did was it executed its playbook not once but across multiple industries. It didn't wait until it perfected its playbook in one industry, because as Sean told me, you will perpetually put it off because you'll never feel like you've gotten there. Building a leading publication in a single industry is hard but also has a fairly low ceiling, if you're trying to build a big company. (I tend to think more people should be OK building a great company that's smaller and skip the lure of massive exits.) Industry Dive was able to pull that off. And finally, I think there's something to be said about how Sean and his team went about building their work without all the PR nonsense. I hope of the many things that are left behind from the previous era, it's the out of whack ratio between sizzle and steak. Fake it till you make it always struck me as a terrible strategy. Ask Ozy. 

For this episode of Making Media, Dom and I sit down with Sean Griffey, CEO and Co-Founder of Industry Dive. When I first heard Sean talk about B2B media and his strategy for building Industry Dive, I needed to hear more. I devoured a ton of his podcast appearances and various interviews that he did because I often feel like conversations on media strategy purely focus on audience growth. They don't ever mention the nuances of who those people are in your audiences, how much you spent to acquire those audiences, and the realities of running a company that can actually just stay in business. Sean is the exact opposite of that and he has built a fascinating business with Industry Dive, which recently sold at an enterprise value north of $500 million. Sean is a great example of the success you can have with a focused strategy. I think there's something to learn regardless of whether you're a content creator or just on the business side of things. Enjoy this interview and our debrief after the conversation. For the full show notes, transcript, and links to the best content to learn more, check out the episode page here.   -----   This episode is brought to you by Scribe. Scribe is the presenting sponsor of this episode of Making Media and the magic behind the Colossus transcripts. One of the best decisions we made at Colossus was transcribing all of our audio into a searchable transcript library. We had been using another provider up until the summer of 2022 but we were constantly having issues with accuracy if our audio was just the slightest bit impaired. Whether it's training sessions, internal Q&As, or for media purposes, the value of transcripts is huge. And we are not alone. Scribe is the transcription service that powers all of S&P Global - like CapIQ - and the client list includes our friends at Tegus. Go to joincolossus.com/scribe to unlock 150 minutes of free transcription and test their capabilities.   -----   Making Media is a property of Colossus, LLC. For more episodes of Making Media, visit joincolossus.com/episodes.   Stay up to date on all our podcasts by signing up to Colossus Weekly, our quick dive every Sunday highlighting the top business and investing concepts from our podcasts and the best of what we read that week. Sign up here.   Follow us on Twitter: @ReustleMatt | @domcooke | @JoinColossus    Show Notes [00:02:45] - [First question] - Overview of Industry Dive and the B2B media industry [00:04:41] - The state of advertisement media versus subscription-based models [00:06:20] - How they maintain consumer trust within their advertising model [00:08:12] - Their strategy for launching into new markets [00:11:42] - How Industry Dive has been able to accelerate their new launches  [00:13:44] - The amount of investment runway they give to new publications [00:15:35] - Industry Dive's standardization across both talent and systems [00:17:40] - Their perspective on advertisement sales [00:19:49] - How they maintain their content production volume at scale [00:21:36] - Their audience growth strategies [00:23:16] - Why consumer platforms like TikTok don't always work for B2B advertising [00:24:45] - How they gather audience feedback [00:26:35] - The importance of their tech stack in audience growth and maintenance  [00:28:30] - How they collaborate with brands in their content studio [00:31:33] - The proportions of their different sources of content [00:32:27] - How margins differ between their content studio and advertising sales [00:33:16] - How they might look to expand their business model in the future [00:34:41] - Why he thinks of marketers as their primary customer [00:35:55] - Their model for reinvestment to further grow their audience [00:37:43] - How the team took advantage of increased digital ad budgets during COVID [00:40:30] - What he worries about most regarding the future of Industry Dive [00:42:12] - Debrief Learn more about your ad choices. Visit megaphone.fm/adchoices

Sean Griffey is the chief executive and co-founder of Industry Dive, a US B2B publisher that was recently acquired by Informa for £323m. Here he speaks to Press Gazette's William Turvill about how he built his business from scratch, why Industry Dive has opted against putting its titles behind paywalls, and future growth plans. Hosted on Acast. See acast.com/privacy for more information.

For our latest season of the Media Voices Podcast, kindly sponsored by Poool, we're be publishing ten episodes exploring the biggest trends of 2022 and how they affect publishers; from subscriptions and membership to advertising, platforms, emerging technology and more. Our fifth episode explores the year in newsletter trends, from worldwide readership to how creators are driving publisher strategies. One of the oldest digital delivery systems of all has continued to dominate industry headlines in 2022 as publishers rethink the way they work with email newsletters. Email-first news publishers have continued to go from strength to strength, with Axios and Industry Dive both acquired this year for significant sums. As overwhelm and news avoidance has grown, email newsletters have been seen as a solution to the firehose of content available online, as Reuters noted in this year's Digital News Report. The trend of journalists leaving outlets to go solo has definitely peaked, with fewer making the move than anticipated. Stability, and the realities of making a living from just a newsletter have stemmed the tide of people taking it from a side hustle to a career. But publishers have responded by finding ways to support talented staff, with Forbes and The Atlantic both having made notable efforts to bring on board dedicated newsletter writers. That's not to say it's been all plain sailing. Facebook (Meta) has binned Bulletin - its Substack competitor - after just over a year. The industry has also been struggling with Apple's Mail Privacy Protection Update, which has made measuring email open rates particularly challenging. This in turn is forcing innovation, and we're likely to see a substantial evolution of both metrics and email advertising over the coming years as publishers seek to bring the premium ad experiences of their sites and apps to their newsletters. Overall, there seems to be an acknowledgement that newsletters have been a long-underserved medium that can actually be incredibly effective for publishers. As the hype has faded, there's a 'more realistic attitude' in place about the format and the business that can be built around it.  Joining us this episode to discuss the biggest newsletter trends of 2022 is Mark Stenberg, Senior Media Reporter at AdWeek in New York. He's reported on some of the biggest newsletter-related media stories of the year, and also has his own newsletter Medialyte. This topic will be one of the chapters we explore in detail as part of our Media Moments 2022 report, launching on November 30th. Find out more and pre-register here to receive the report. This season of Media Voices is sponsored by Poool, the Membership and Subscription Suite used by over 120 publishers from around the world. The team behind Poool are industry experts who have put everything they know into the product, ready to respond to your ‘how' of launching & developing a reader revenue strategy. poool.tech | @PooolTech

Suzanne Struglinski, PR Manager for Industry Dive, joined the A100 podcast to share her insights on earned media and what association comms professionals need to know to improve their media relations efforts. She discusses the disconnect between what association leaders see as news and what reporters see as news, while emphasizing the importance of being a resource for reporters. She also shares thoughts on the unique relationship between PR professionals and journalists. “Reporters want news,” she says. “You need to build those relationships, making sure you understand who you're pitching, why you're pitching and keeping in mind that you want to be a resource to these journalists.” Subscribe today so you never miss out on future episodes. Follow along on social media for best practices, top trends, helpful ideas and smart strategies and tactics that work in the world of associations: Twitter: @association100 LinkedIn: /company/the-association-100 Follow Suzanne or reach out via email: Twitter: @SuzanneStrug LinkedIn: /in/suzannestruglinski/ Email: sstruglinski@industrydive.com

Kate Tornone, Lead Editor with Industry Dive and HR Dive, joins ProjectHR to discuss the 2022 Identity of HR Survey!

The business of hip hop is often overlooked, even though it's a massive business with outsized cultural influence. Dan Runcie saw this as an opportunity, starting Trapital in 2018. I wanted to talk to Dan about his approach to building an independent media brand. He's already established himself and Trapital as an authority on the hip hop business. Trapital now has over 16,000 subscribers, with the publication supported almost entirely through sponsorships. Dan had earlier done a paid model, but pivoted to free when realizing he could reach far more people without the friction of a paywall – and a value proposition that appeals to sponsors like Moonpay, Convertkit and Alts.. Some takeaways from our conversation: Hip hop punches above its weight. There's a school of thought that niche business publications are best in “unsexy” areas, as Industry Dive showed in its focus on big nuts-and-bolts business sectors. But cultural industries have influence beyond their size. Trapital isn't about news. Dan has made a point of saying what he does is not journalism but business analysis. Part of that is to be clear the product isn't a tool for keeping up to date on the ins and outs of the industry. Instead of the play-by-play, Trapital focuses on the context with Stratchery-like essays on topics like “how The Weeknd mastered his brand” and “Beyonce's streaming strategy, explained.” The pivot from subscriptions. For the past couple years, all roads have led to subscriptions in publishing as the travails of the big digital publishers have cast a pall on the ad model. But as Industry Dive, Axios and others have shown, advertising can be the great focal point of a publishing business model – if the audience is a group that's hard to reach and valuable. In 2018, Trapital scrapped its initial paid model. Often subscriptions are painted as a set-it-and-forget-it option, but making money is hard no matter the model, and subscriptions require constant selling and marketing. Dan saw as a one-person operation this was cutting into his focus. Instead, Trapital focused on an “influence” model that initially treated the newsletter and podcast as lead gen for consulting, while adding in advertising and moving into investing. Going beyond solo. Trapital is working as a one–person business, but Dan wants to expand beyond just himself. The challenge is how to do this without losing the personal touch since Trapital's brand is very tied into Dan's perspective.

Why would a huge European event business snap up a relatively unknown media company? In this 5-minute tear down, Adam Ryan has the answers. Join Adam as he shares his personal experience talking to Industry Dive CEO Sean Griffey, why Informa has done the math, and some of the challenges they'll face going forward. You'll hear Adam's spicy takes on whether this vertical play will convert, why media is always an execution game, and why going deeper with the audience is Informa's next challenge. To hear Adam's original interview with Sean, listen here: https://bit.ly/3J1ulcM (https://bit.ly/3J1ulcM) And if you love listening to Media Moves, please leave me a 5-star review on Rate My Podcast: https://ratethispodcast.com/mediamoves (https://ratethispodcast.com/mediamoves) Thank you so much! Keep up to date with the latest Media Moves news. Follow Adam on Twitter: https://twitter.com/AdamRy_n (https://twitter.com/AdamRy_n) Sign up to the Perpetual newsletter: https://workweek.com/brand/perpetual (https://workweek.com/brand/perpetual)

Joe and Robert break down the latest Netflix results and the launch of their ad-supported model. And apparently TikTok is going to replace Google for search, while all designers and artists are afraid of AI. Raves include a surpise kudos from Robert to the ANA, while Joe breaks down the Informa purchase of Industry Dive. This week's articles: Netflix Ad-Supported Model TikTok Is the New Google for Gen Z DALLE 2, AI and Graphic Design ANA's New Influencer Guide Informa Buys Industry Dive --------- Liked this show? SUBSCRIBE to this podcast on Spotify, Apple, Google and more. Catch past episodes and show notes at ThisOldMarketing.site. Subscribe for the best in content creation at TheTilt.com.

David Cancel of Drift, Peep Laja of Wynter, Chris Savage of Wistia, Niel Robertson of Influence.co, Stephen Lease of Goodr, Gary Swart, formerly of Upwork, Shafqat Islam of NewsCred, Sean Griffey of Industry Dive, Vaibhav Jain of Hublio, Rand Fishkin of Sparktoro, Jimmy Daly of Superpath, and Eric Remer of EverCommerce share wisdom of all sorts based on their experiences as founders and CEOs.

Sean Griffey is a rare commodity. Not only is he a legend in the media operating space, he's also the man to go to for insightful commentary on where media is heading. There aren't many media operators who can say they've bootstrapped a business to more than $100m in annual revenue but if anyone was going to, it was Sean. Adam zooms in on Sean's B2B company, Industry Dive, helping decision-makers stay one step ahead of the competition with insightful journalism in niche industries. They discuss how Sean chooses the categories he jumps into and what he thinks about paid acquisition for his company. You'll hear Sean talk about regrets from his earliest days, before zooming out to look at the media landscape as a whole and Sean's predictions on future trends. Sean's a media operator with knowledge that's second to none. It's a trait he shares with episode sponsor Sailthru. Their platform is designed to build relationships with an audience who move the needle for your business. Find out more here: https://www.sailthru.com/ (https://www.sailthru.com) Follow Sean: LinkedIn: https://www.linkedin.com/in/seangriffey (linkedin.com/in/seangriffey) Twitter: https://twitter.com/seangriffey (twitter.com/seangriffey) Keep up to date with the latest Media Moves news. Follow Adam on Twitter: https://twitter.com/AdamRy_n (twitter.com/AdamRy_n) Sign up to the Perpetual newsletter: https://workweek.com/brand/perpetual (workweek.com/brand/perpetual)

Today I'm joined by Kathryn Moody. Kathryn is a Senior Editor at Industry Dive where she oversees their HR focused publication, HR Dive. In this episode, we talk about what HR professionals are most interested in; the importance of broccoli content, and doubling down on newsletters.

In just a few short years, Sean Griffey and his team at Industry Dive have built an impressive B2B media company. But even if you're not in B2B, there is a lot that ANY media company can learn from their approach and success.As a digital media company built from scratch, Industry Dive currently serves 23 industries with 53 email newsletters. They have over 2.5 million email subscribers and last year did over $100 million in revenue at a 30% EBITDA margin.During this session, Sean and I talk about:How Industry Dive got started.How email is the key to their success.How they built an email database of 2.5 million active B2B email subscribers.How websites fit into the strategy and thoughts on the longevity of email.How Industry Dive chooses their business model and industries.Why they acquired a content studio as part of their business.What's next for Industry Dive and B2B media in general?Learn more at https://nearviewmedia.com/

Phoebe Bain founded Marketing Brew, a Morning Brew vertical covering the most important news in the marketing industry, in 2020. The vertical has since expanded into original reporting and beyond the newsletter. She's now one of five reporters the Brew has since added to the fold, and primarily covers social media and influencer marketing. Before rolling out Marketing Brew, Phoebe wrote for Social Media Today under Industry Dive and worked on the social media editing desk for Business Insider. Here are a few of the topics we'll discuss on this episode of Long Story Short:   How to effectively keep your finger on the pulse of your industry Phoebe's meta view of marketing and advertising The current, biggest trends of the marketing industry Changes in social media, engagement, and the world of influencer marketing The benefits of talking to, and learning from, industry experts Why authentic marketing strategies resonate better with audiences The difference between writing and reporting  Resources:Maybe Baby - Haley NahmanMorning BrewMarketing BrewGarbage DayTrick Mirror - Jia TolentinoConnect with Phoebe:LinkedInTwitterInstagramConnect with the Host:Jeff Sirkin on LinkedInConnect with Sirkin Research:WebsiteTwitterInstagramLinkedIn

On this week's episode we hear from Jakub Parusinski, founding editor at The Fix, a trade magazine for media professionals. He and Peter spoke about Jakub's background across journalism and management consulting, and how that has informed the nuts and bolts approach the Fix takes to ‘cracking the media management puzzle'. In the news roundup the team discuss crypto's incursions into legacy media. We talk about the BBC pulling a documentary hours before it aired after the Guardian raised some concerns about the validity of its subject's claims, and Forbes' bizarre association with both a crypto scammer named Razzlekhan and its subsequent receipt of a $200m investment from crypto exchange Binance. In the news in brief we discuss Twitter's results, the closure of Entertainment Weekly as a print title, and the laudable success of Industry Dive's newsletter network. They said a sub-40 minute episode of Media Voices was impossible, but we dared to dream.

En este episodio, Mauricio Cabrera está acompañado por Ernesto Martelli, Mario Szekely y Eduardo Tessler para abordar las siguientes temáticas: 1.- La extinción del periodismo profundo de cine y TV en LATAM 2.- Estado actual de los medios en Brasil 3.- ¿Qué significa el éxito de Industry Dive y Front Office Sports como medios de híper nicho? Más información aquí: https://www.storybaker.co/p/industry-dive-fos-y-la-oportunidadSuscríbete a The Muffin: https://www.storybaker.co/Descarga Tendencias 2022: http://tendenciasmedia.com/ Hosted on Acast. See acast.com/privacy for more information.

Industry Dive co-founder and CEO Sean breaks down marketing lessons from a media company, the problem with precision marketing, and the blessing (and curse) of bootstrapping.

B2B content titan Sean Griffey joins us (again!) to discuss Industry Dive and their approach to niche in the B2B media space.

Subscribe on Apple Podcasts and SpotifyThis week, I'm wrapping up the first mini-season of The Rebooting Show. This season was dedicated to modern B2B businesses. If you haven't already, please check out the first four episodes of the season:Adam White of Front Office Sports discussed the advantages of bootstrapping.Julia Noran Johnston of Business of Home shared how she found an underserved niche in interior designers.Angus Macaulay of Stat explained its Politico-like model for life sciences.Industry Dive's Sean Griffey spoke about the advantages of finding valuable but overlooked industry segments.To cap off the season, this week's episode is what I'm calling a Spotlight episode. This is an opportunity for the underwriter of the season to explain how they're partnering with publishers to build sustainable media businesses. I treat these podcasts like all the others, and I only work with companies addressing real problems in the building of sustainable media businesses. This week's Spotlight episode is  a conversation with Bernard Urban, CEO of Silverblade Partners, a strategic finance partner to publishers agencies and ad tech firms. Thanks to Silverblade for being The Rebooting Show's launch sponsor.When I started to report on the media business, two things quickly became clear that I found odd: nobody could agree on how to measure audiences, and nobody paid each other on time. Publishers and agencies always complained bitterly about crazy payment terms. The way it usually works is those with the most leverage, ie the most money, force the smaller party to wait for long periods of time, up to 180 days.Of course, the problem is your everyday costs as a business – salaries, rent, tech systems – are constant, creating a cashflow crunch. Stretched payment terms has created a velocity mismatch: The media business moves incredibly fast, only the financial system underpinning it slogs along like molasses. For many publishers, this means running a business with high fixed costs in terms of salaries, benefits, rent and more while the financing structure means publishers often wait a long time to get paid. That's why I was happy to partner with Silverblade Partners to sponsor the first season of The Rebooting Show. With access to over $1 billion in financing, Silverblade has the financial resources to solve liquidity challenges arising from outstanding accounts receivable for most media companies. Silverblade was founded by veterans of the media industry, with a deep understanding of the particular nuances of the business that your average bank simply does not have. Silverblade has built a cashflow solution that will finance accounts receivable and accounts payable on more flexible and favorable terms than an option like factoring from a bank. Bernard and I spoke about some of the basics of trade finance, why traditional cashflow solutions like lines of credit or factoring are a mismatch for advertising media, and why finance should be a strategic function within media companies. Let me know any feedback you have on the episode: bmorrissey@g

Subscribe on Apple Podcasts and SpotifyThis week's episode of The Rebooting Show features a conversation I had with one of my favorite media success stories: Industry Dive, a collection of vertical industry sites. Sean and his team have grown Industry Dive into an example of a sturdy media business, on pace to break the $100 million in revenue mark next year with healthy margins. One request: If you listen to The Rebooting Show on Apple Podcasts, please leave a rating and review. Thanks to Alfred Westcott, who left a very nice review that ranked me “one of the best interviewers in media.”Industry Dive is one of the most successful modern digital media businesses, even if it doesn't get the attention of splashy consumer titles.Sean Griffey, who founded Industry Dive in 2012 along with Ryan Willumson and Eli Dickenson, doesn't mind flying under the radar compared to splashy consumer brands while Industry Dive focuses on industry verticals like retail, marketing, utilities and more. “This is a better business. It's great you're targeting millennial fashion consumers, but I'm in the electric utilities space and that matters to everyone. The industries we write about touch every person. I leaned into the boring part because I know it's important. You call it boring, I call it profitable.”It helps that Sean has receipts.340 employees2.5 million email subscriptions25 publications$85 million in revenue this year, $100 million expected next yearEBITDA margins above 25%Here are key takeaways from our conversation:Details matterFor all the talk of vision, the media business is an execution game. Industry Dive began in 2012 with a handful of publications and the idea that it would differentiate by providing a better user experience, focusing on the right industries, and sticking to what the team knew best.“We thought there would be a chance to use the mobile experience to differentiate ourselves. We wanted to invest heavily in design. In business media it was pretty horrific. We wanted to invest in content. We thought niche media had abandoned that for leads over time.”The power of nicheScale and niche aren't in opposition as often presented. But many digital media companies born around the time of Industry Dive took a different path. They focused more on general news audiences instead of specific areas. Industry Dive developed a formula for targeting industry sectors.Industries changing rapidly due to tech and/or regulationHigh capital spendingA buy and a sell sideEvidence of a vibrant market in the form of competing publications and trade shows“There's real value in 100,000 incredibly targeted, valuable people. In each of these markets, you could create a $10-20 million business, just marketing supported. But if you wanted a $500 million business, you had to do it a lot. For us it was how do you build a scaled niche business.”Email is more than just a delivery mechanismEmail is the lifeblood of B2B media, allowing a direct connection to an audience – and a way to collect relevant information to understand the audience better. That's why Industry Dive email subscribers can have a lifetime value of of hundreds of dollars.“It's a platform you own and nobody can take away. More importantly, it's a push platform. There are very few things you can push to audiences vs pull, where they come to you. Email is also personally identifiable. You can start tyin

Is Disney going metaverse? Of course they are, but should they at this point? Joe and Robert discuss exactly what Disney needs to do (and, of course, they will be correct). Miramax is suing Quentin Tarantino over his launch of "Pulp Fiction" NFTs. Joe believes there are major legal landmines here, while Robert believes it's all a marketing stunt. Speaking of NFTs and marketing stunts, this Industry Dive article goes through what brands are doing now to take advantage of the NFT run. Phase 1 is all stunts and short-sighted marketing. Phase 2 will be all about utility. Rants and raves include a DAO buying the US Constitution and Netflix's new power rankings. --------- Liked this show? SUBSCRIBE to this podcast on Spotify, Apple, Google and more. Catch past episodes and show notes at ThisOldMarketing.site.

This one's for all the creatives and marketers out there who've ever had people think that all they do is “arts and crafts.” As we know, it's so much more. Design departments can no longer be underestimated as they touch nearly every aspect of a business. As brand touchpoints continue to multiply exponentially, each moment needs to be thought through on a visual and emotional level. Industry Dive's creative director, Chelsea Ennis, has helped grow the design department to prove, with no uncertainty, how valuable creative output can be. In this episode, we talk with Chelsea about what it took to scale the design department, prove that it was worth the effort, and how she led her fast-growing team throughout the process. Having worked with brands like Target, Home Depot, Twitter, and IBM, Chelsea got her start at digital agency Group SJR as a graphic and web designer. She eventually found herself at Industry Dive, where she helped build up a talented design team that works with brands to tell better stories. Over her career her skills spread the gamete, from design project management, leading and scaling creative teams to and marrying the design strategy with business needs. All of which shaped her into the creative director that she is today.

Content expert Marna Palmer works with nurse writers frequently in her role at studioID. Learn what she seeks in a “unicorn” freelance writer. Episode Summary Marna Palmer is the Director of Operations at studioID, a major content marketing agency and brand studio. Every day she works with clinician writers and has some great insights into how nurses can differentiate themselves in LOIs, what studioID looks for in a nurse writer, and exactly what you should do when following up on an LOI to rise to the top of the list. About Marna Palmer: If Marna could create her own business card it would say "Professional Cat Herder," as that has been the most consistent theme of her career; from celebrities to creatives, she finds talent, helps it grow and assists in keeping everyone organized while making money in the process. She spent the first 10 years of her career as a talent agent in Los Angeles negotiating commercial endorsements for her celebrity clients. She then went to the other side of the desk and joined a marketing startup, where she led the publishing team's B2C digital marketing efforts and thus began her work with freelance writers. Since then, she has worked with content creators of all kinds around the world; at companies in Los Angeles, Oslo, Norway and now at studioID in Washington, DC. Host Elizabeth Hanes BSN RN built a six-figure writing business in her spare time. Today, she coaches other nurses how to become freelance writers through the RN2writer project. Topics discussed in this episode Here's a sampling of what you can learn in this episode: - The huge role that clips and a portfolio play in whether or not an agency brings you on as a writer [6:06] - Why showcasing your subject matter expertise as a nurse can win you a role with an agency [8:20] - How studioID built such an amazing culture by seeking input from their freelance writers [9:59] - What is the distinction between B2C and B2B marketing? [11:01] - What are the top three attributes of the “unicorn” freelancer? [14:58] - How nurses can use content marketing to elevate their own brand [20:02] - The importance of having an online presence [21:14] - What is the real future of healthcare content marketing? Is this a bad time to jump in as a nurse writer? [24:06] - Should aspiring content marketing writers develop their journalism skills? [26:16] - The best way to follow up on LOIs without being annoying [27:45] Quotable “As someone who's looking for freelance writers, if I go onto someone's LinkedIn profile and I don't see anything, I'm like, ‘Ooh.' Or if I Google them, and I can't find a website, I have no idea if I should take a chance on them.” – Marna Palmer, studioID “There are so many non-writing skills that are equally or more important to editors and clients: being easygoing, being flexible, being fun to work with, meeting the deadline. Writing skill – while you need it, and you should continue to hone it – is not at the top of the list of what clients value necessarily in a nurse who writes.” – Elizabeth Hanes “Prospective clients are not going to look at your blog to see how well you write. They're going to look to see if you're up on the industry trends, and do you know what's going on in the industry, and then how are you explaining that through your prose.” – Elizabeth Hanes “I think the content marketing industry in healthcare is just going to constantly expand. I don't think there's every going to be a shortage of [writing opportunities].” – Marna Palmer, studioID “If you're showing up in my inbox at a reasonable cadence with relevant content so that I don't have to go [searching] on LinkedIn, you're making my life easier.” – Marna Palmer, studioID Resources mentioned in this episode studioID: https://www.studioid.com/ Industry Dive: https://www.industrydive.com/ LinkedIn: https://www.linkedin.com Next steps Download and listen to the podcast of this episode at RN2writer Start your journey from nursing to writing with the ebook Design Your Dream Career as a Nurse Writer Follow RN2writer on social media: Instagram, Facebook, Twitter, LinkedIn

This week we’re joined by Jacob Bell, a senior reporter for BioPharma Dive. In his role, Jacob covers the FDA, big pharma, and drugmakers. He has held positions at Industry Dive including reporter and associate editor and has reported for other notable outlets including The Deal, TheStreet, and McClatchy. On the episode, Jacob tells us about pitches that grab his attention and ones that completely miss the mark, his preference for sources using bullets, his hopefulness for the future of journalism, and more.

Today on Coffee with a Journalist, we’re chatting with Jane Thier, an associate editor for CFO Dive. Jane covers the news surrounding financial executives from major companies to politics and universities. She previously worked for Sauce Magazine, SmartAsset, and Thunderfoot as an editorial intern. During the episode, Jane tells us more about the various publications underneath Industry Dive, how often she is producing stories and what she includes in them, what she values in a pitch, and more.

On today’s episode, we’re joined by Peter Adams, a reporter for Marketing Dive - an umbrella company of Industry Dive. Peter’s coverage includes news, updates, and cultural trends in the marketing industry and most recently has written about the industry shifts due to COVID-19, marketing amidst social movements, and generational consumer behavior. Today, Peter shares about his favorite canned coffee, what makes Marketing Dive’s daily newsletter unique, the types of stories you can pitch him, and more.

Sean Griffey is co-founder and CEO of Industry Dive, a network of business publications covering a wide variety of topics including retail, biopharma and waste management. When I think about a successfully scaled b2b media company, Industry Dive comes to mind first. In this episode, we discussed a ton, but a few things jumped out… On expanding into new markets Industry Dive has a specific playbook that they use to determine what verticals they want to expand into it. It starts with a very simple question: does this fit the business model? Because Industry Dive is marketing driven, it needs to find industries with high capital spend. That means the executives are buyers that control budgets. A mistake Sean sees many operators make is that they in industries that don't have this. The other very important question they ask is whether the industry is being disrupted by technology or regulation. What they're trying to identify is whether people's jobs require them to keep up to date on what's going on day-to-day. If that exists, you've got something. On media's sweet spot with content studios Industry Dive recently acquired the content studio from NewsCred in what appears to have been a match made in heaven. NewsCred was moving away from its content studio business while Industry Dive was doubling down on it. What this reinforces is the sweet spot that media finds itself with regarding to producing content for partners. As Sean explains, any agency can create great content. That's not the hard part. They might even be able to create great content and distribute that content to an audience (though not as easily as a media company can.) Only a media company can take it a step farther and consult their clients on when the narrative has shifted. Industry Dive was able to tell its partners, “hey, the audience is moving away from covid-related coverage” far faster than an agency ever could, which allowed their partners to start creating new content in the new narrative. On data being the most important thing Sean offered his big piece of advice for prospective media operators and it's something that I whole heartedly agree with as well. Operators need to start collecting user data immediately. You'll never feel bad having a better understanding of who your audience is. More importantly, the sooner you have it, the better it'll be when you decide to use it. And using it doesn't have to mean advertising products. Having better user data can also mean making better product and editorial decisions. In Sean's opinion, too many media companies wait to determine their user data strategy and they'd be smart to start sooner.

On this week's Brand Story Inc., we're joined by Industry Dive CEO Sean Griffey. He offers realistic insights into identifying underserved audiences, creating quality, targeted content, and how to seamlessly integrate a new content studio into a thriving model.

Brian Dolan, Founder & Lead Writer at Exits & Outcomes, is the first guest on the show and for good reason. He has had multiple careers in media, first working for Fierce Markets (which seems to have trained multiple future operators), then launching MobiHealthNews, which was then sold and, most recently, creating Exits & Outcomes. In this show, we discussed a variety of important topics, but a few things jumped out. Having an advisory committee As Brian explains it, the acquisition of MobiHealthNews was something they hoped would happen, but was certainly not a given. Multiple times he and his co-founder would go out to lunch with executives from HIMSS, but it was only after a few years that the conversations turned more serious. One thing that Brian admits would have helped was having people that he could call on to help him out. Having people that could relate to the situation would have made things simpler when going through the exercise of getting acquired. By and large, a tight network of advisors can be invaluable for discussing ideas and getting a gut check on whether an idea is good. Pricing for subscriptions The blend of art vs. science for pricing subscriptions was certainly alive during this discussion. The way he did it was straight forward: what were other people charging for similar content? By finding comparable rates, he knew he was in a good place. One thing Brian doesn't offer that I do is a monthly rate. His logic makes sense: the value of his market research is too high to let someone access it for a month for only $20 and then unsubscribe immediately afterward. At $200 a year, it's still a good value. What comes next with an idea toward bundling There are two potential paths he has thought about taking... The first is that he could go the route of replicating the success he has had with Exits & Outcomes and expand into other verticals outside of digital health. That would require bringing on additional writers and effectively taken a script from FierceMarkets and Industry Dive. The second (and more likely course) is to find more niches within digital health. Healthcare is a huge industry, so there are plenty of niches within that. It's a more likely way to go that he could continue operating as a solopreneur without needing to bring other people on board. This second approach would result in a sort of bundle for his subscribers, providing multiple different high-quality digital health insights that would keep his subscribers from leaving.

First, watch the Nike ad if you haven't. Required watching. TikTok was in the news this week, with a crazy deal in progress with Microsoft. In other news, Industry Dive purchased Newscred's content marketing studio business, while Digiday finds that branded content and native advertising spending is on a downward trend. Freightwaves media business has taken off and Buzzfeed now sells products (of course they do). Robert has another Quibi update and comments on Tom Goodwin's firing from Publicis. Joe loves the launch of The 19th, and comments about the closing of Folio: magazine. This week's sponsor: Content Marketing World ------ Subscribe to PNR: This Old Marketing at Apple Podcasts, Google Podcasts, Stitcher, iHeartRadio, Spotify or wherever you listen to fine podcasts. Subscribe to Joe Pulizzi's Random Newsletter at JoePulizzi.com. Follow Joe @JoePulizzi. Joe's new #thriller is now available at TheWilltoDie.com. Also, get Joe's Corona Marketing book free. Subscribe to Robert Rose's newsletter at The Content Advisory. Follow Robert @Robert_Rose.

Ever wondered how to get your product in the news? For this episode, we sat down with Industry Dive editor, Natalie Koltun. She tells us what she looks for when deciding whether or not to write an article for a company. She also shares with us her strategy for ethically marketing a product that won’t be released for another 4 years. 3:44 The ethics behind marketing for a product that may not come out for another 4 years6:00 The favorite part of her job and the most challenging part of her job8:00 Advice for entrepreneurs who want to be in the news9:40 How writing a book peaked her interest in marketing12:00 Natalie’s from POOP to GOLD moment16:12 How much time she spends on her articlesYou can find links to Natalie Koltun’s LinkedIN profile and twitter handle below.If you’re interested in learning more about Harmon Brothers, you can grab a copy of our book at harmonbrothersbook.com Don’t forget to like, subscribe, and share. Episodes published every Tuesday at 6 am EST. We’ll see you on the next one.Find Natalie Koltun Here:https://www.linkedin.com/in/nataliekoltun/https://twitter.com/natalie_koltun

I rarely get into the realm of politics but today’s episode is a particularly important opportunity for us to take action. Today’s episode is focused on what’s happening right now in a petition to the Federal Energy Regulatory Commission (FERC) by a secretive group called the New England Ratepayers Association (NERA) aimed at stripping away your solar rights, namely, the Net Energy Metering regulations that have stood for nearly a decade as Federally approved rules. Have a listen as I speak with Catherine Morehouse of Industry Dive and Glen Brand of Solar United Neighbors to unpack what this petition is all about and what we can do to stop it. Remember you can always find the resources and learn more about today’s guest, recommendations, book links and more than 260 other founder stories and startup advice at www.mysuncast.com. Gain access to all the show notes & resources from this episode here You can connect with the host, Nico Johnson, on Twitter, LinkedIn or email Thanks a ton to our podcast sponsors for continuing to help make this content FREE to You! Please check them out and let me know what you think!

I rarely get into the realm of politics but today’s episode is a particularly important opportunity for us to take action. Today’s episode is focused on what’s happening right now in a petition to the Federal Energy Regulatory Commission (FERC) by a secretive group called the New England Ratepayers Association (NERA) aimed at stripping away your solar rights, namely, the Net Energy Metering regulations that have stood for nearly a decade as Federally approved rules. Have a listen as I speak with Catherine Morehouse of Industry Dive and Glen Brand of Solar United Neighbors to unpack what this petition is all about and what we can do to stop it. Remember you can always find the resources and learn more about today’s guest, recommendations, book links and more than 260 other founder stories and startup advice at www.mysuncast.com. Gain access to all the show notes & resources from this episode here You can connect with the host, Nico Johnson, on Twitter, LinkedIn or email Thanks a ton to our podcast sponsors for continuing to help make this content FREE to You! Please check them out and let me know what you think!

When we talk about the media industry, we’re usually discussing publishers that are geared toward a broad audience -- outlets like The New York Times or CNN or NPR. Even more niche publications like The Verge or Bon Appetit are designed to attract tens of millions of readers each month. But there’s also an entire ecosystem of business-oriented publishers that operate in extremely narrow niches -- outlets aimed at sewage workers, electricians, and grocery store executives. Though their readerships are relatively small, they represent industries that collectively generate hundreds of billions of dollars each year. Because of this, B2B niche publishers, when run well, can be immensely profitable. Industry Dive is one such B2B publisher. Founded in 2012, the company now produces publications that cover over a dozen industries. I sat down with one of its co-founders Sean Griffey to talk about Industry Dive’s origin story and how it bootstrapped its way to north of $22 million in annual revenue.

Where the article came from in this podcast is from social media Explorer! They provide a fundamental analysis of the latest happenings in the social media industry. Social Media Today is a leading industry publication operated by Industry Dive. Our journalists spark ideas and shape agendas for 5+ million decision-makers in the most competitive industries. Article: https://socialmediaexplorer.com/digital-marketing/how-can-a-social-media-agency-boost-your-instagram-account/If you want to learn more about a subject you can email us with the subject line: podcast2learn Host: Tyson Greenan Compass 9 media --- Send in a voice message: https://anchor.fm/social-media-compass/message

Where the article came from in this podcast is from social media today! They provide a fundamental analysis of the latest happenings in the social media industry. Social Media Today is a leading industry publication operated by Industry Dive. Our journalists spark ideas and shape agendas for 5+ million decision-makers in the most competitive industries. Article: https://www.socialmediatoday.com/news/survey-social-media-platform-and-content-plans-for-2020/569557/ If you want to learn more about a subject you can email us with the subject line:podcast2learn Compass 9 media Host: Tyson Greenan LinkedIn | Instagram | Tiktok --- Send in a voice message: https://anchor.fm/social-media-compass/message

Without a doubt, one of the biggest trends in the food & beverage industry during 2019 was hard seltzers. Whether you were at a bar, a sporting event, a concert, or a friend's BBQ, it was nearly impossible to miss these incredibly trendy drinks. But the most intriguing thing about this trend wasn't necessarily the low-ABV carbonated beverages itself, but rather how brands like White Claw utilized social media and the power of peer influence to boost sales. This week, on Just a Taste, we spoke with Lillianna Byington, Associate Editor at Industry Dive, to discuss why hard seltzers were incredibly popular this year, and what's next for the industry now that more brands have entered the market.

Industry Dive was one of B2B’s most successful (and contrarian) independent publishers, more than doubling revenue without dabbling in events or acquisitions that have driven growth for so many other publishers. Now that private equity has come calling, how does Industry Dive expand while retaining its formula of culture and content that’s worked so well? Featuring Industry Dive CEO Sean Griffey, and Keynote Speaker at the upcoming Business Information & Media Summit, November 11-13 in Hollywood Beach, Florida.

In a time when trade or business news publications are struggling to survive, one company is killing it. Industry Dive publishes business news and analysis for executives through dedicated sites and email newsletters. What Industry Dive does may not sound sexy, but its revenue stream is turning heads. On this episode of Brandstorm, Industry Dive’s Robin Re, VP of Marketing, talks about Industry Dive’s successful business model. Industry Dive’s Story After years of working together in digital media, Industry Dive’s founders Sean Griffey, Ryan Willumson and Eli Dickinson began to notice a consistent trend. They saw that, while mobile devices were changing the way people worked and consumed information, traditional business media content models, user interfaces and marketing programs were slow to adapt. In 2012, they launched Industry Dive to meet the needs of busy industry executives: providing insights and analysis to help them do their jobs. Its first five publications included Construction Dive, Education Dive, Marketing Dive, Utility Dive and Waste Dive. Five years ago, today’s guest, Robin Re, joined the company to contribute to its growth. Today, there are 16 publications with another two planned to launch this year, its reach has expanded to eight million professionals and its revenues have grown to more than $20 million. Competitive Differentiators As Industry Dive’s name implies, the journalists dive deep into the business news headlines to not only report the story, but to provide insight and analysis of what the information means to its readers. Its editorial is 100 percent independent with a staff of 66 full-time journalists. Robin cites competition, change and capital as its formula for deciding which vertical markets to enter. The industry must already be covered by a niche media group, be subject to continual change because of technology and regulations, and have a large, capital spend. Revenue Generation Industry Dive’s newsletters are free to its readers and 100 percent ad-supported. Banner ads are less than 10 percent of its revenues. They don’t use programmatic ads, but sell directly to its advertisers using lead generation campaigns and direct response vehicles that include email platforms and high-end content like playbooks and webinars. Its sales force are more like consultants who sell “sponsorships” based on the goals of its advertising partners and craft campaigns that speak to its valuable niche audiences. Results are also evaluated primarily on the number of leads or downloads generated and not impressions. The company expects to reach $29 million in revenues in 2019 and will employ about 150 by the end of the year. Connect with Industry Dive: The best way to communicate with Robin is to subscribe to one of its publications at: https://www.industrydive.com/industries/ She responds to everyone who writes to the publication. Robin's LinkedIn: https://www.linkedin.com/in/robinselvy/ IndustryDive's LinkedIn:https://www.linkedin.com/company/industry-dive IndustryDive's Twitter: https://twitter.com/industrydive Robin's Twitter: https://twitter.com/robinselvy IndustryDive's Facebook: https://www.facebook.com/IndustryDive/

Industry Dive, an online-only B2B company based in Washington D.C., is a good proof point that the sky is not falling for all "ad-dependent" media. Founder & CEO Sean Griffey discussed the reasons why he wants to stick to the ad model for Industry Dive, stretching brands across the several industries they cover and their ability to make measured bets in their business.

Sean Griffey, co-founder and CEO of Industry Dive, discusses how his company's innovative method of sourcing niche news for specific demographics, like industry CEOs and presidents, allows the company to create close relationships with businesses and communities while also maintaining strong, reliable revenue on the internet.

Naomi Eide of CIO Dive joins the podcast to discuss her reporting, data privacy issues and much more! "Naomi Eide edits CIO Dive with busy executives in mind. She keeps pace with the ever-changing world of tech; from emerging cyberthreats to sussing out the impact of future tech on business. Originally from Washington state, Naomi moved to the capital area to pursue her Master's in journalism from the University of Maryland, College Park. When she's not performing on the bassoon with a local orchestra, Naomi is crushing culinary competitions (Industry Dive pie contest champion, two years running)."